The Harrington Prize for Innovation in Medicine
The ASCI/Harrington Prize for Innovation in Medicine is a collaboration between the ASCI and the Harrington Discovery Institute at University Hospitals Case Medical Center. The Prize, established with its first recipient in 2014, honors a physician-scientist who has moved science forward with achievements notable for innovation, creativity, and potential for clinical application. The Prize carries a $20,000 honorarium, a lectureship at the ASCI’s annual meeting, and publication of a personal essay in the Journal of Clinical Investigation.
2017: Daniel J. Drucker, MD, Joel F. Habener, MD, and Jens J. Holst, MD, DMSc
The fourth annual Harrington Prize for Innovation in Medicine has been jointly awarded to Daniel J. Drucker, MD (Mount Sinai Hospital, Canada), Joel F. Habener, MD (Massachusetts General Hospital, USA) and Jens J. Holst, MD, DMSc (University of Copenhagen, Denmark) for their discovery of incretin hormones and for the translation of these findings into transformative therapies for major metabolic diseases such as diabetes.
2016: Jeffrey M. Friedman, MD, PhD
The third annual Harrington Prize for Innovation in Medicine has been awarded to Jeffrey M. Friedman, MD, PhD, of the Rockefeller University.
2015: Douglas R. Lowy, MD
The second annual Harrington Prize for Innovation in Medicine has been awarded to oncologist and researcher Douglas R. Lowy, MD, Chief, Laboratory of Cellular Oncology, and Deputy Director of the National Cancer Institute.
2014: Harry Dietz, MD
The inaugural Harrington Prize for Innovation in Medicine was awarded to pediatric cardiologist and genetics researcher Harry Dietz, MD, of The Johns Hopkins University School of Medicine.